A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer

NCT02747342 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm
Prostate Cancer

Interventions

DRUG: SHR3680; SHR3162

Sponsor

Atridia Pty Ltd.